Dopamine receptor D3 mRNA expression in human lymphocytes is negatively correlated with the personality trait of persistence

Journal of Neuroimmunology

Volumn 150, Issue 1-2, 2004, Pages 145-149

  Czermak, Christoph ^a,b,c   Lehofer, Michael ^b,c   Renger, Helmut ^c   Wagner, Elke M ^a   Lemonis, Leonidas ^b,d   Rohrhofer, Alfred ^b,d   Schauenstein, Konrad ^a   Liebmann, Peter M ^a,b  

^a UNIVERSITY OF GRAZ   (Austria)

^b Addiction Research Society   (Austria)

^c Sigmund Freud Clinics   (Austria)

^d Drug Rehab Center Gruener Kreis   (Austria)

Author keywords

Human; Lymphocytes; Messenger; Personality; Polymerase Chain Reaction; Receptors, dopamine; RNA

Indexed keywords

DOPAMINE 3 RECEPTOR; MESSENGER RNA;

ADULT; ARTICLE; CHARACTER; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; HUMAN; LYMPHOCYTE; MALE; MULTIFACTORIAL INHERITANCE; NORMAL HUMAN; PERSONALITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; TEMPERAMENT; VARIANCE;

ADULT; ANALYSIS OF VARIANCE; EXPLORATORY BEHAVIOR; FEMALE; GENETIC MARKERS; HUMANS; LYMPHOCYTE SUBSETS; MALE; PERSONALITY; PERSONALITY INVENTORY; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D3; RECEPTORS, DOPAMINE D4; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; STATISTICS, NONPARAMETRIC;

EID: 1842636918     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2004.01.009     Document Type: Article

References (32)

1. Barbanti P., Bronzetti E., Ricci A., Cerbo R., Fabbrini G., Buzzi M.G., Amenta F., Lenzi G.L. Increased density of dopamine D5 receptor in peripheral blood lymphocytes of migraineurs: a marker for migraine? Neurosci. Lett. 207:1996;73-76.
2. Barbanti P., Fabbrini G., Ricci A., Bruno G., Cerbo R., Bronzetti E., Amenta F., Luigi L.G. Reduced density of dopamine D2-like receptors on peripheral blood lymphocytes in Alzheimer's disease. Mech. Ageing Dev. 120:2000;65-75.
3. Barbanti P., Fabbrini G., Ricci A., Pascali M.P., Bronzetti E., Amenta F., Lenzi G.L., Cerbo R. Migraine patients show an increased density of dopamine D3 and D4 receptors on lymphocytes. Cephalalgia. 20:2000;15-19.
4. Benjamin J., Li L., Patterson C., Greenberg B.D., Murphy D.L., Hamer D.H. Population and familial association between the D4 dopamine receptor gene and measures of Novelty Seeking. Nat. Genet. 12:1996;81-84.
5. Bergquist J., Tarkowski A., Ekman R., Ewing A. Discovery of endogenous catecholamines in lymphocytes and evidence for catecholamine regulation of lymphocyte function via an autocrine loop. Proc. Natl. Acad. Sci. U. S. A. 91:1994;12912-12916.
6. Bondy B., Ackenheil M. 3H-spiperone binding sites in lymphocytes as possible vulnerability marker in schizophrenia. J. Psychiatr. Res. 21:1987;521-529.
7. Bondy B., Ackenheil M., Birzle W., Elbers R., Frohler M. Catecholamines and their receptors in blood: evidence for alterations in schizophrenia. Biol. Psychiatry. 19:1984;1377-1393.
8. Bondy B., Ackenheil M., Elbers R., Frohler M. Binding of 3H-spiperone to human lymphocytes: a biological marker in schizophrenia? Psychiatry Res. 15:1985;41-48.
9. Bondy B., de Jonge S., Pander S., Primbs J., Ackenheil M. Identification of dopamine D4 receptor mRNA in circulating human lymphocytes using nested polymerase chain reaction. J. Neuroimmunol. 71:1996;139-144.
10. Cloninger C.R., Przybeck T.R., Svrakic D.M., Wetzel R.D. The temperament and character inventory (TCI): a guide to its development and use. German translation. Center for Psychology of Personality. 1999;Washington University, St. Louis, MO.
11. Cohen J.D., Braver T.S., Brown J.W. Computational perspectives on dopamine function in prefrontal cortex. Curr. Opin. Neurobiol. 12:2002;223-229.
12. Comings D.E., Gade-Andavolu R., Gonzalez N., Wu S., Muhleman D., Blake H., Mann M.B., Dietz G., Saucier G., MacMurray J.P. A multivariate analysis of 59 candidate genes in personality traits: the temperament and character inventory. Clin. Genet. 58:2000;375-385.
13. Felten D.L., Felten S.Y., Bellinger D.L., Carlson S.L., Ackerman K.D., Madden K.S., Olschowki J.A., Livnat S. Noradrenergic sympathetic neural interactions with the immune system: structure and function. Immunol. Rev. 100:1987;225-260.
14. Grodzicki J., Pardo M., Schved G., Schlosberg A., Fuchs S., Kanety H. Differences in [3H]-spiperone binding to peripheral blood lymphocytes from neuroleptic responsive and nonresponsive schizophrenic patients. Biol. Psychiatry. 27:1990;1327-1330.
15. Ilani T., Ben Shachar D., Strous R.D., Mazor M., Sheinkman A., Kotler M., Fuchs S. A peripheral marker for schizophrenia: increased levels of D3 dopamine receptor mRNA in blood lymphocytes. Proc. Natl. Acad. Sci. U. S. A. 98:2001;625-628.
16. Josefsson E., Bergquist J., Ekman R., Tarkowski A. Catecholamines are synthesized by mouse lymphocytes and regulate function of these cells by induction of apoptosis. Immunology. 88:1996;140-146.
17. Kiyatkin E.A. Functional significance of mesolimbic dopamine. Neurosci. Biobehav. Rev. 19:1995;573-598.
18. Koob G.F., Riley S.J., Smith S.C., Robbins T.W. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi and olfactory tubercle on feeding, locomotor activity, and amphetamine anorexia in the rat. J. Comp. Physiol. Psychol. 92:1978;917-927.
19. Kwak Y.T., Koo M.S., Choi C.H., Sunwoo I. Change of dopamine receptor mRNA expression in lymphocyte of schizophrenic patients. BMC Med. Genet. 2:2001;3.
20. Lusher J.M., Chandler C., Ball D. Dopamine D4 receptor gene (DRD4) is associated with Novelty Seeking (NS) and substance abuse: the saga continues. Mol. Psychiatry. 6:2001;497-499.
21. Meador-Woodruff J.H., Damask S.P., Wang J., Haroutunian V., Davis K.L., Watson S.J. Dopamine receptor mRNA expression in human striatum and neocortex. Neuropsychopharmacology. 15:1996;17-29.
22. Nagai Y., Ueno S., Saeki Y., Soga F., Yanagihara T. Expression of the D3 dopamine receptor gene and a novel variant transcript generated by alternative splicing in human peripheral blood lymphocytes. Biochem. Biophys. Res. Commun. 194:1993;368-374.
23. Nagai Y., Ueno S., Saeki Y., Soga F., Hirano M., Yanagihara T. Decrease of the D3 dopamine receptor mRNA expression in lymphocytes from patients with Parkinson's disease. Neurology. 46:1996;791-795.
24. NCBI - National Center for Biotechnology Information. NCBI BLAST Home Page. http://www.ncbi.nlm.nih.gov/BLAST/. Last access on 25-7-2002.
25. Orlando C., Pinzani P., Pazzagli M. Developments in quantitative PCR. Clin. Chem. Lab. Med. 36:1998;255-269.
26. Perl O., Ilani T., Strous R.D., Lapidus R., Fuchs S. The alpha7 nicotinic acetylcholine receptor in schizophrenia: decreased mRNA levels in peripheral blood lymphocytes. FASEB J. 17:2003;1948-1950.
27. Ricci A., Bronzetti E., Mignini F., Tayebati S.K., Zaccheo D., Amenta F. Dopamine D1-like receptor subtypes in human peripheral blood lymphocytes. J. Neuroimmunol. 96:1999;234-240.
28. Slominski A., Goodman-Snitkoff G.G. Dopa inhibits induced proliferative activity of murine and human lymphocytes. Anticancer Res. 12:1992;753-756.
29. Takahashi N., Nagai Y., Ueno S., Saeki Y., Yanagihara T. Human peripheral blood lymphocytes express D5 dopamine receptor gene and transcribe the two pseudogenes. FEBS Lett. 314:1992;23-25.
30. Tang L., Todd R.D., O'Malley K.L. Dopamine D2 and D3 receptors inhibit dopamine release. J. Pharmacol. Exp. Ther. 270:1994;475-479.
31. Tsao C.W., Lin Y.S., Cheng J.T. Inhibition of immune cell proliferation with haloperidol and relationship of tyrosine hydroxylase expression to immune cell growth. Life Sci. 62:1998;L-44.
32. Wong A.H., Buckle C.E., Van Tol H.H. Polymorphisms in dopamine receptors: what do they tell us? Eur. J. Pharmacol. 410:2000;183-203.